These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27620302)

  • 21. [Correlation study between interleukin-17 and ESR and CRP in serum and the synovial fluid of rheumatoid arthritis patients of accumulated dampness-heat obstruction in joints syndrome].
    Liu DF; Yan J; Guo MY; Wang C; Hu YH; Yang M; Yun MD; Luo Y; Zhang J; Li H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):272-5. PubMed ID: 24758074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative analysis of selected interleukins and proinflammatory factors in CSF among de novo diagnosed patients with RRMS.
    Morawiec N; Techmański T; Tracz K; Kluska A; Arendarczyk M; Baran M; Adamczyk B; Czuba Z; Bronikowska J; Adamczyk-Sowa M
    Clin Neurol Neurosurg; 2023 Feb; 225():107522. PubMed ID: 36706701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis.
    Liu Y; Ho RC; Mak A
    Int J Rheum Dis; 2012 Apr; 15(2):183-7. PubMed ID: 22462422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis.
    Yang L; Zhang J; Tao J; Lu T
    APMIS; 2015 Dec; 123(12):1025-31. PubMed ID: 26547368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
    Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
    Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
    Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica.
    Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A
    Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-22+ CD4+ T cells in patients with rheumatoid arthritis.
    Zhao L; Jiang Z; Jiang Y; Ma N; Zhang Y; Feng L; Wang K
    Int J Rheum Dis; 2013 Oct; 16(5):518-26. PubMed ID: 24164838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis.
    Kostic M; Dzopalic T; Zivanovic S; Zivkovic N; Cvetanovic A; Stojanovic I; Vojinovic S; Marjanovic G; Savic V; Colic M
    Scand J Immunol; 2014 Mar; 79(3):181-6. PubMed ID: 24383677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased serum levels of interleukin-35 among multiple sclerosis patients may be related to disease progression.
    Badihian S; Shaygannejad V; Soleimani P; Mirmosayyeb O; Samee Z; Manouchehri N; Esmaeil N
    J Biol Regul Homeost Agents; 2018; 32(5):1249-1253. PubMed ID: 30334421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation.
    Stabler T; Piette JC; Chevalier X; Marini-Portugal A; Kraus VB
    Arthritis Rheum; 2004 Nov; 50(11):3663-7. PubMed ID: 15529362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
    Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
    Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
    Guerrero-García Jde J; Castañeda-Moreno VA; Torres-Carrillo N; Muñoz-Valle JF; Bitzer-Quintero OK; Ponce-Regalado MD; Mireles-Ramírez MA; Valle Y; Ortuño-Sahagún D
    Neuroimmunomodulation; 2016; 23(1):8-17. PubMed ID: 26599431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K; Bartosik-Psujek H; Mitosek-Szewczyk K; Belniak-Legieć E
    Med Sci Monit; 2000; 6(6):1104-8. PubMed ID: 11208463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis.
    Rasmussen TK; Andersen T; Hvid M; Hetland ML; Hørslev-Petersen K; Stengaard-Pedersen K; Holm CK; Deleuran B
    J Rheumatol; 2010 Oct; 37(10):2014-20. PubMed ID: 20682664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.